Background
==========

Recently there have been attempts to correlate published microarrays, using software that can analyze many thousands of microarrays at one time. One such program is called Oncomine™ \[[@B1]\], where each study within Oncomine™ is in essence a collection of individual microarrays from many patient samples\[[@B2]\]. These \"multi-arrays\" usually utilise either normal or tumour biopsy samples (or compare both together), from various tissue sources.

One function of Oncomine™ is a search tool where the user\'s chosen gene is correlated in expression, within multi-arrays, with other genes in the array (both high and low expression, over all the samples in the multi-array). For example searching p72 (*DDX17*) gives several correlations in many multi-arrays. Focusing within the study Whitney_normal there is a high correlation with expression of fibrillarin, over the 147 blood samples tested (Figure [1A](#F1){ref-type="fig"}). In samples where p72 expression was diminished, so was fibrillarin, and conversely when p72 expression was high, so is that of fibrillarin. This result is made more significant given that p72 and fibrillarin have previously been shown to interact together\[[@B3]\].

![**Oncomine studies utilised and methodology of analysis**. (A) Screenshot example of Oncomine™ output of p72 (*DDX17*) coexpression with fibrillarin (*FBL*) in one multi-array study, covering 147 samples. p72 is X-axis and fibrillarin is Y-axis. (B) Procedure employed for meta-analysis of 19 different multi-arrays after searching for either p68 or p72, extracting the top 400 coexpressed genes from each multi-array, and comparing for frequency of repetition. (C) Chosen multi-arrays to be studied for both p68 and p72.](1471-2164-8-419-1){#F1}

Correlations like this can show if proteins may be in the same pathway (e.g. both coregulated together, or one directly affecting the other), although it cannot show more than association. In an attempt to further increase the stringency of Oncomine™ to elude to these pathways we chose to test the DEAD-box proteins p68 and p72 because they are highly similar proteins that interact together and have been shown to be involved in defined cellular functions including splicing and transcription, which can then be used as a quality control measure of this technique \[[@B4]-[@B10]\]. Also as p68 and p72 are so similar there is the possibility that they may to some extent be functionally redundant.

In total this means that we can perform a meta-analysis of p68 coexpressed genes independent to that of p72, then compare the results for overlap (Figure [1B](#F1){ref-type="fig"}). If the gene lists were to give a significant overlap then this would act to support the notion that the technique is highly selective. Our results reveal that, not only does this technique corroborate previously published data on p68 and p72, it also generates testable predictions of novel pathway partners of p68 and p72.

Results
=======

Overlapping coexpressed genes of p68 and p72
--------------------------------------------

Multi-arrays chosen for meta-analysis had many individual samples/microarrays, indicating that a good correlation coefficient given by Oncomine™ is already highly significant. Figure [1C](#F1){ref-type="fig"} indicates the chosen multi-array studies for p68 and p72. Note that there is almost a 50% overlap of studies chosen.

Meta-analysis results, with frequency of 3 or more, for p68 yielded a higher volume of hits than for p72 (see Additional file [1](#S1){ref-type="supplementary-material"}). Both of these lists were compared for common genes and the common list was further assessed for ontology and full gene names (Table [1](#T1){ref-type="table"}). Remarkably, we observed a large number of overlapping genes, indicative of the stringency employed in this technique.

###### 

Frequency overlap between p68 and p72 coexpressed genes.

  Gene                                                p68 %     p72 %     Function                               Gene Name
  --------------------------------------------------- --------- --------- -------------------------------------- ----------------------------------------------------------------------------------------------------------------
  TIA1                                                26%       16%       Splicing                               cytotoxic granule-associated RNA-binding protein
  SFRS5                                               **37%**   21%       Splicing                               splicing factor, arginine/serine-rich, 5
  SFPQ                                                **42%**   **47%**   Splicing                               splicing factor proline/glutamine rich (polypyrimidine tract binding protein associated)
  SF1                                                 **37%**   26%       Splicing                               splicing factor 1
  MBNL1                                               **53%**   **32%**   Alternative Splicing                   muscleblind-like protein(Triplet-expansion RNA-binding protein)
  HNRPH1                                              **47%**   **32%**   Splicing                               heterogeneous nuclear ribonucleoprotein H (hnRNP H)
  CROP                                                21%       **37%**   SR Protein -Splicing?                  cisplatin resistance-associated overexpressed protein (LUC7A)
  CPSF2                                               **42%**   21%       Splicing                               cleavage and polyadenylation specificity factor
  C6orf111                                            **32%**   **32%**   Splicing                               splicing factor, arginine/serine-rich 130
  FLJ12529                                            21%       16%       Splicing                               pre-mRNA cleavage factor I, 59 kDa subunit
  DDX5                                                100%      26%       Splicing/Transcription                 p68 DEAD-box RNA helicase
  DDX17                                               26%       100%      Splicing/Transcription                 p72 DEAD-box RNA helicase
  PAPOLA                                              26%       21%       Transcription/Splicing                 poly(A) polymerase alpha
  ILF3                                                26%       21%       Transcription/Splicing                 NFAR1/NF-90/subunit of NFAT transcription factor
  PNN                                                 16%       21%       Transcription/Splicing                 pinin(DRS)
  XBP1                                                26%       21%       Transcription/ER-alpha pathway         X-box binding protein 1
  THRAP2                                              **32%**   21%       Transcription?                         thyroid hormone receptor associated protein 2
  RORA                                                26%       26%       Transcription                          RAR-related orphan receptor alpha
  PTMA                                                21%       16%       Transcription                          prothymosin, alpha (gene sequence 28)
  DHX9                                                **47%**   **32%**   Transcription                          RNA Helicase A/DEAH (Asp-Glu-Ala-His) box polypeptide 9
  BMI1                                                21%       16%       Transcription Silencing                B lymphoma Mo-MLV insertion region (mouse) \[Polycomb complex protein BMI-1\]
  SMARCA2                                             16%       21%       Transcription                          SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
  HIF1A                                               16%       16%       Transcription                          hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
  MAP3K7IP2                                           26%       21%       Signal Transduction/Transcription      mitogen-activated protein kinase kinase kinase 7 interacting protein 2 (TAB2)
  PRKAR1A                                             **47%**   **32%**   Signal Transduction                    protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)
  PIK3R1                                              21%       21%       Signal Transduction                    phosphoinositide-3-kinase, regulatory subunit 1 (p85 alpha)
  HIPK2                                               **32%**   16%       Signal Transduction/Apoptosis          homeodomain interacting protein kinase 2
  DNAJC3                                              21%       16%       Signal Transduction                    DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor)
  CSNK1A1                                             **32%**   21%       Signal Transduction                    casein kinase 1, alpha 1
  GNAS                                                21%       21%       Receptor-Stimulated G-Protein          guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1
  ABI2                                                26%       21%       Cytoskeleton                           Abl-interactor 2 (Abelson interactor 2)
  ARPC3                                               21%       26%       Cytoskeleton                           actin related protein 2/3 complex, subunit 3, 21kDa (p21-ARC)
  FNBP4                                               26%       21%       Cytoskeleton?                          formin binding protein 4
  WASPIP                                              16%       16%       Cytoskeleton                           Wiskott-Aldrich syndrome protein interacting protein
  UTRN                                                16%       21%       Cytoskeleton                           utrophin (homologous to dystrophin)
  RAP2A                                               16%       16%       Cytoskeleton?                          RAP2A, member of RAS oncogene family
  NEDD5                                               16%       21%       Cytoskeleton/cell-cycle?               septin 2 (GTP-binding protein family)
  ACTB                                                16%       26%       Cytoskeleton                           beta actin
  MAPRE2                                              16%       16%       Cytoskeleton                           microtubule-associated protein, RP/EB family, member 2
  SDCBP                                               21%       21%       Scaffold Protein                       syndecan binding protein (syntenin)
  HNRPU                                               **42%**   **32%**   Nuclear Matrix Attachment              heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A)
  XPO1                                                26%       21%       Nuclear Export                         exportin 1 (CRM1 homolog, yeast)
  TNPO1                                               26%       32%       Nuclear Import                         transportin 1
  NUP133                                              26%       16%       Nuclear Pore                           nuclear pore complex protein Nup133
  ZFR                                                 26%       21%       Nuclear RNA binding                    zinc finger RNA binding protein
  RAB5A                                               16%       16%       Endocytosis                            RAB5A, member RAS oncogene family
  RAB6A                                               **68%**   16%       Golgi-ER trafficking                   RAB6A, member RAS oncogene family
  GDI2                                                26%       26%       ER-golgi?(Interacts Rab6, above)       rab GDP-dissociation inhibitor, beta
  EDEM1                                               21%       **32%**   Calnexin cycle/protein folding         ER degradation enhancer, mannosidase alpha-like 1
  RAB14                                               **32%**   26%       Golgi-endosome trafficking             RAB14, member RAS oncogene family
  PLEKHB2                                             26%       16%       post-golgi vesicle protein             pleckstrin homology domain containing, family B (evectins) member 2
  TMP21                                               **37%**   **37%**   Trafficking                            transmembrane trafficking protein
  TRAM1                                               26%       16%       Protein Translocation                  translocation associated membrane protein 1
  SLC38A2                                             21%       21%       Amino acid transport                   Solute carrier family 38, member 2
  SLC25A5                                             26%       25%       ADP/ATP carrier protein                Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5
  CGI-109                                             **37%**   16%       Protein transport?                     hypothetical protein
  USP9X                                               21%       16%       Ubiquitin                              ubiquitin specific protease 9, X chromosome (Drosophila fat facets related)
  UBE2J1                                              21%       **32%**   Ubiquitin                              ubiquitin-conjugating enzyme E2, J1 (UBC6 homolog, yeast)
  UBE3A                                               16%       21%       Ubiquitin                              ubiquitin protein ligase E3A
  BIRC6                                               16%       21%       Ubiquitin ligase/Anti-apoptosis        baculoviral IAP repeat-containing 6 (apollon)
  BIRC2                                               **32%**   21%       Apoptosis-resistance                   baculoviral IAP repeat-containing 2
  PSMA2                                               21%       21%       Proteasome                             proteasome (prosome, macropain) subunit, alpha type, 2
  PIAS1                                               26%       21%       E3-SUMO Ligase                         protein inhibitor of activated STAT, 1 (DEAD/H box-binding protein 1)
  MAK3                                                21%       16%       N-acetyltransferase                    Mak3 homolog (S. cerevisiae)
  PFAAP5                                              21%       21%       Immune?                                phosphonoformate immuno-associated protein 5
  MCP                                                 **32%**   26%       Immune                                 membrane cofactor protein (CD46, trophoblast-lymphocyte cross-reactive antigen)
  SMBP                                                26%       16%       Membrane protein                       SM-11044 binding protein
  MKLN1                                               21%       21%       Ischemic tolerance/Cell adhesion?      muskelin 1, intracellular mediator containing kelch motifs
  ALDOA                                               26%       16%       Metabolism (glycolysis)                aldolase A, fructose-bisphosphate
  IDI1                                                **32%**   26%       Metabolism                             isopentenyl-diphosphate delta isomerase
  CYB5-M                                              26%       16%       Metabolism                             cytochrome b5 outer mitochondrial membrane precursor
  GLO1                                                **37%**   21%       Metalloglutathione (GSH) transferase   glyoxalase I
  EIF3S6                                              21%       16%       Translation                            eukaryotic translation initiation factor 3, subunit 6 48kDa
  EIF1AX                                              16%       21%       Translation                            eukaryotic translation initiation factor 1A
  PCBP2                                               16%       16%       Translation                            poly(rC) binding protein 2 (hnRNPE2)
  HNRPA2B1                                            32%       21%       Cell proliferation?                    heterogeneous nuclear ribonucleoprotein A2/B1
  CDK6                                                16%       16%       Cell-cycle                             cyclin-dependent kinase 6
  CCNE2                                               16%       16%       Cell-cycle                             G1/S-specific cyclin E2
  PUM2                                                26%       21%       Meiosis/RNA-binding                    pumilio homolog 2 (Drosophila)
  TRA2A                                               16%       26%       RNA-binding/?                          transformer-2 alpha (putative MAPK activating protein PM24)
  ATXN2                                               16%       21%       ? (but has RNA motif)                  ataxin 2
  GTF2IP1                                             21%       26%       Pseudogene                             general transcription factor II, i, pseudogene 1
  H41                                                 **53%**   26%       ?                                      hypothetical protein
  C19orf13                                            26%       **37%**   ?                                      family with sequence similarity 61, member A (FAM61A)
  CNIH                                                26%       26%       ?                                      cornichon homolog (TGAM77)
  LOC400986                                           26%       26%       ?                                      protein immuno-reactive with anti-PTH polyclonal antibodies (HEM1)
  ANKRD17                                             21%       21%       ?                                      ankyrin repeat domain 17 (breast cancer antigen NY-BR-16)
  RHOBTB3                                             16%       16%       ? (GTPase)                             Rho-related BTB domain containing 3
  ? - Unknown or unidentified gene product function                                                              

90 genes were identified to be both coexpressed with p68 and p72, and are arranged by function. For clarity all coexpressed gene products with a 30% or greater coexpression frequency correlation for either p68 or p72 are in **bold**.

Even when the stringency was further augmented by increasing the p68 frequency cut-off to 4 or more multi-arrays (21% and above overlap within p68 multi-arrays), this lost almost 300 p68 hits, but only reduced the number of overlapping genes with p72 from 90 to 70 (Figure [2A](#F2){ref-type="fig"}). The highest frequency of overlap of p68 and p72 occurred in splicing, consistent with previous reports of their role in this process. Further validation of this technique was observed by the reciprocal gene hits of p68 and p72 (i.e. p72 was a positive for p68 and vice-versa), again consistent with their interaction within the same pathways.

![**Analysis of overlap of p68 and p72 coexpressed genes**. (A) Venn diagram of overlap of frequency = 3 or more, genes from p68 and p72 analysis, and when p68 frequency is increased to 4 or more. (B) Ontology pie-chart of p68/p72 overlapping frequency = 3 or more, gene products.](1471-2164-8-419-2){#F2}

The next most abundant function of p68 and p72 appeared to be in transcription (Figure [2B](#F2){ref-type="fig"}), once more consistent with previous reports. This is especially interesting given that p68 and p72 were previously shown to act as coactivators for the nuclear receptor estrogen receptor α (ERα) transcription factor, and we have identified X-box binding protein 1 (*XBP1*), associated with the ERα pathway. We have also identified 2 other nuclear receptor pathway proteins, the thyroid hormone receptor associated protein 2 (*THRAP2*) and the retinoic acid receptor-related orphan receptor α (*RORA*) transcription factor.

RNA Helicase A(Dhx9) coexpresses and interacts with p68 and p72
---------------------------------------------------------------

A further interesting transcription-associated gene identified was RNA helicase A (*DHX9*), a member of a similar protein family to p68 and p72, all of which have been shown to interact with p300/CBP coactivators\[[@B6],[@B11]-[@B13]\]. The frequency for both p68 and p72 were observed to be high for RNA helicase A (almost 50% of multi-arrays for p68, and over 30% for p72).

For this reason a similar coexpression analysis was separately performed for *DHX9*. Surprisingly, not only were p68 and p72 reciprocally coregulated with *DHX9*, but over 50% of the p68:p72 overlapped positives were also coexpressed with *DHX9*(47 out of 90 -- see Additional file [2](#S2){ref-type="supplementary-material"}). This was powerful evidence linking Dhx9, p68 and p72 to similar pathways.

As this overlap was so high it was possible that p68 and p72 were functioning in the same complex as Dhx9. This was tested experimentally in HEK293 cells. With immunoprecipitation of either transiently transfected p68 or p72 we observed a clear interaction with endogenous Dhx9 (figure [3A](#F3){ref-type="fig"}). Further imunoprecipitations of endogenous p68 and p72 from lysate of mouse liver confirmed the interaction with Dhx9 (figure [3B](#F3){ref-type="fig"}). This was performed after incubation with RNaseA, indicating a protein:protein interaction (as p68/p72/Dhx9 can all bind RNA). In the liver extract p68 and p72 also strongly immunoprecipitated a protein of 100 kDa, recognised by the Dhx9 antibody (figure [3B](#F3){ref-type="fig"}). It currently remains unclear if this is a different isoform of Dhx9 or a cross-reacting protein.

![**p68 and p72 interact directly with predicted pathway partner Dhx9**. (A) Left panel shows myc immunoblot of inputs from transiently transfected myc-p68 or -p72, or vector alone. Right panel shows RNA helicase A (Dhx9) immunoblot of inputs and myc immunoprecipitations (IP). (B) Dhx9 immunoblot of endogenous IP of p68 and p72 from mouse liver lysate (RNase A pre-treated). \* Indicates either a shorter Dhx9 isoform or a cross-reacting (but immuno-precipitating) protein.](1471-2164-8-419-3){#F3}

Altogether, these data both supported the hypothesis of p68/p72/Dhx9 existing within the same complex, and further acted as strong evidence of the predictive capabilities of the Oncomine™ analysis technique described here.

Other coexpressed genes of p68 and p72
--------------------------------------

Interestingly, there were 4 overlapped hits in the ubiquitin pathway (and one proteasome) which may be related to the observation that p68 is highly ubiquitinated in colon cancers\[[@B14]\]. p68 was also recently shown to be SUMO modified, specifically SUMO-2 by PIAS1 ligase\[[@B15]\]. Here we shown that *PIAS1*is coexpressed with p68/p72, and *SUMO-2*is coexpressed with p68.

p68/p72 have also recently been shown to interact in a complex with ILF3, hnRNPU, and hnRNPH1 for microRNA processing\[[@B16]\]. Here, these gene products are also shown to be highly coexpressed with p68 and p72, supporting their role in the same complex/pathway (furthermore *DDX3X*is identified here with p68 and is also part of this microRNA processing complex).

In a separate study a group of proteins were identified in an mRNP complex with p68 and are here shown to be coexpressed with p68/p72 (*SFRS5*, *NFAR/ILF3*, *HNRNPA2/B1*, *HNRPU*, *PNN*, *TRA2A*, *DDX3X*) \[[@B17]\].

A new role for p68 and p72, suggested by our meta-analysis, might be in nuclear transport, given that a member of nuclear pore complex (Nup133) as well as nuclear import (transportin1) and export (exportin1) genes were identified as coexpressed genes.

Furthermore, coexpressed genes presented here are not limited to nuclear processes given that several cytoskeletal proteins are identified in the screening, implicating p68 and p72 in these processes (although probably indirectly as p68 and p72 are predominantly nuclear, perhaps acting via transcription or splicing). This is also true for endoplasmic reticulum (ER) or golgi proteins. Indeed, the *RAB6A*trafficking protein had the highest frequency overlap for p68 (almost 70% overlap), while being one of the lowest for p72 (16% overlap), possibly indicative of a functional difference between both. The family member *RAB14*was also identified for both.

A further significant group of genes identified were involved in signal transduction, and may provide a start into analysis of regulation of p68 and p72 (although a meta-analysis like this can identify frequency of coexpression, it is impossible to say which protein may be regulating another, or indeed if both are targets of another protein).

Altogether the results of the overlapping coexpressed genes not only reiterate previous studies with either p68/p72 but predict new potential pathways in which p68/p72 may act.

Selected non-overlapping coexpressed genes of p68 and p72
---------------------------------------------------------

While p68 and p72 may be highly similar and involved in the same pathways, it remains likely that they are also involved in subtly different pathways. For this reason a similar ontology analysis was performed on genes that do not overlap between p68 and p72. However, given the extensive nature of the gene hits we selected all genes with frequency overlap above 30%, as well as some genes of interest from lower frequencies (Table [2](#T2){ref-type="table"}).

###### 

p68 and p72 frequency analysis of non-overlapping hits (all over 30% and selected below 30%).

  [p68 selected genes with no p72 overlap]{.ul}                                                                                                       
  ------------------------------------------------------------------------------------- --------------- --------------------------------------------- --------------------------------------------------------------------------------
  FXR1                                                                                  **42%**         RNA-binding/Unknown                           fragile X mental retardation, autosomal homolog 1
  HNRPK                                                                                 **37%**         Transcription/Translation/Signaling           heterogeneous nuclear ribonucleoprotein K
  NAP1L1                                                                                **32%**         Transcription                                 nucleosome assembly protein 1-like 1
  JMJD1C                                                                                **32%**         Transcription                                 jumonji domain containing protein 1C (Thyroid receptor interacting protein 8)
  SFRS11                                                                                **32%**         Splicing                                      splicing factor, arginine/serine-rich 11
  MAPRE1                                                                                **37%**         Cytoskeleton                                  microtubule-associated protein, RP/EB family, member 1
  ACTG2                                                                                 **32%**         Cytoskeleton                                  actin, gamma 2, smooth muscle, enteric
  PTPN11                                                                                **32%**         Signal Transduction                           protein tyrosine phosphatase, non-receptor type 11 (Noonan syndrome 1)
  JAK1                                                                                  **32%**         Signal Transduction                           janus kinase 1 (a protein tyrosine kinase)
  ARF3                                                                                  **32%**         Vesicular Trafficking                         ADP-ribosylation factor 3
  ANXA7                                                                                 **32%**         ER-calcium mobilization                       annexin A7 (Annexin VII) (Synexin)
  COX7A2L                                                                               **32%**         Metabolism                                    cytochrome c oxidase subunit VIIa polypeptide 2 like
  C6orf55                                                                               **32%**         Anti-metastatic protein                       protein C6orf55 (Dopamine responsive protein DRG-1) (My012 protein)
  LAPTM4A                                                                               **32%**         compartmentalization of amphipathic solutes   lysosomal-associated protein transmembrane 4 alpha
  ZNF9                                                                                  **32%**         ?                                             zinc finger protein 9 (a cellular retroviral nucleic acid binding protein)
  TDE1                                                                                  **32%**         ?                                             tumor differentially expressed 1
  SYPL                                                                                  **32%**         ?                                             synaptophysin-like 1
  NUCKS                                                                                 **32%**         ?                                             nuclear, casein kinase and cyclin-dependant kinase substrate
  ELK3                                                                                  26%             Transcription                                 ELK3, ETS-domain protein (SRF accessory protein 2)
  THRAP1                                                                                21%             Transcription                                 thyroid hormone receptor associated protein 1
  RBBP4                                                                                 21%             Transcription                                 retinoblastoma binding protein 4 (chromatin assembly factor/CAF-1 p48 subunit)
  ERBP                                                                                  21%             Transcription                                 estrogen receptor binding protein
  RARA                                                                                  16%             Transcription                                 retinoic acid receptor, alpha
  HDAC2                                                                                 16%             Transcription                                 histone deacetylase 2
  SNRPB                                                                                 26%             Splicing                                      small nuclear ribonucleoprotein polypeptides B and B1
  TAPBP                                                                                 26%             ER chaperone/Protein folding                  TAP binding protein (tapasin)
  CALR                                                                                  21%             ER chaperone/Protein folding                  calreticulin
  CANX                                                                                  16%             ER Chaperone/Protein folding                  calnexin
  RAB1A                                                                                 26%             ER-golgi Transport                            RAB1A, member RAS oncogene family
  RAB11B                                                                                21%             Membrane recycling                            RAB11B, member RAS oncogene family
  UCHL1                                                                                 21%             Ubiquitin                                     ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
  PSMA2                                                                                 21%             Proteolysis                                   proteasome (prosome, macropain) subunit, alpha type, 2
  PRKWNK1                                                                               21%             Proteolysis                                   proteasome (prosome, macropain) 26S subunit, non-ATPase, 1
  SUMO2                                                                                 16%             SUMO pathway                                  small ubiquitin-like modifier, 2
  CDC42                                                                                 21%             Cell-cycle                                    cell division cycle 42 (GTP binding protein, 25kDa)
  CDC40                                                                                 21%             Cell-cycle                                    cell division cycle 40 homolog (yeast) \[pre-mRNA splicing factor 17\]
  CDC10                                                                                 26%             Cytokinesis?                                  septin-7 (CDC10 protein homolog)
  LITAF                                                                                 26%             p53-induced Apoptosis                         lipopolysaccharide-induced TNF factor (p53-induced protein 7)
  EIF3S10                                                                               26%             Translation                                   eukaryotic translation initiation factor 3, subunit 10 theta, 150/170 kDa
                                                                                                                                                      
  [p72 selected genes with no p68 overlap]{.ul}                                                                                                       
  **Gene**                                                                              **% Overlap**   **Function**                                  **Gene Name**
  TTC3                                                                                  **32%**         ?                                             tetratricopeptide repeat domain 3
  HMGN4                                                                                 26%             Transcription                                 high mobility group nucleosomal binding domain 4
  CTBP1                                                                                 21%             Transcription/corepressor                     C-terminal binding protein 1
  MTA1                                                                                  21%             Transcription/ER-alpha repressor              metastasis associated 1
  HDAC7A                                                                                16%             Transcription                                 histone deacetylase 7A
  NONO                                                                                  16%             Splicing/Transcription                        non-POU domain containing, octamer-binding (p54nrb)
  SFRS3                                                                                 16%             Splicing                                      splicing factor, arginine/serine-rich 3
  MAP2K3                                                                                26%             Signal Transduction                           mitogen-activated protein kinase kinase 3
  ERBB3                                                                                 16%             Signal Transduction                           receptor protein-tyrosine kinase erbB-3
  CSK                                                                                   16%             Signal Transduction                           c-src tyrosine kinase
  CALM2                                                                                 16%             Signal Transduction                           calmodulin 2 (phosphorylase kinase, delta)
  RPS6                                                                                  21%             Ribosome                                      40S ribosomal protein S6
  RPS15A                                                                                21%             Ribosome                                      40S ribosomal protein S15a
  MRPS6                                                                                 26%             Mitochondrial Ribosome Protein                mitochondrial ribosomal protein S6
  PABPC1                                                                                26%             Translation                                   poly(A) binding protein, cytoplasmic 1
  EIF5                                                                                  21%             Translation                                   eukaryotic translation initiation factor 5
  EDD                                                                                   26%             ubiquitin E3 Ligase                           ubiquitin\--protein ligase EDD
  ARPC3                                                                                 26%             Cytoskeleton                                  actin related protein 2/3 complex, subunit 3,21 kDa
  WSB1                                                                                  21%             ?                                             WD repeat and SOCS box-containing 1
  GARNL1                                                                                21%             ?                                             GTPase activating RANGAP domain-like 1
  ?-Genes with unknown function. Genes with \> 30% frequency overlap are in **bold**.                                                                 

All coexpressed but non-overlapping gene products for p68 and p72 over 30% frequency are shown (and are in **bold**). Selected coexpressed gene products below 30% are shown and were chosen based on interest and common ontology groups.

For p68 the genes above 30% generally fell into the same categories as previously, while there was only 1 gene identified for p72, with no obvious molecular function. Of-course the selected genes below 30% were chosen based on interest and common ontological groupings, and may not be representative. However, we note that for p68 more RAB family members are identified (*RAB1A*, *RAB11B*) as well as more ER proteins, particularly protein folding chaperones (Tapasin, Calnexin, Calreticulin).

With regard to transcription, p68 coexpressed with *ELK3*and *HDAC2*transcriptional repressors, while p72 coexpressed with *CTBP1*and *HDAC7*repressors. This might be relevant given that p68 and p72 have been shown to act as transcriptional repressors, hypothesised to have different mechanisms of action as they act in a promoter-specific manner\[[@B7]\]. However it has been shown that CTBP1 repressive function is antagonized by pinin\[[@B18]\], and here, both p68 and p72 also coexpress with pinin (*PNN*)\[[@B17]\]. p68 has also been shown to be involved in p53 coactivation\[[@B4]\], and here we identify a coexpressed p53 coactivator hnRNPK\[[@B19]\] for p68/p72 and the p53-induced protein 7 (*LITAF*), for p68. For other transcription roles for p68 there were more nuclear receptor pathway proteins including thyroid receptor interacting protein 8 (*JMJD1C*),*THRAP1*(*THRAP2*was identified above for both p68 and p72), estrogen receptor binding protein (*ERBP*), and the retinoic acid receptor alpha (*RARA*) transcription factor. p72 coexpressed with the ER-alpha repressor *MTA1*. We have also observed that p68 coexpressed gene *ZNF9*is in the same pathway as p68/p72 coexpressed *MBNL1*, implicated in myotonic dystrophy\[[@B20]\].

For p72 we note that NonO (p54nrb) has been shown to interact with SFPQ/PSF\[[@B21]\] (*SFPQ*identified as coexpressed for both p68 and p72). Furthermore EDD (a ubiquitin E3 ligase), also identified here with p72, has been shown in a complex with SFPQ\[[@B22]\]. Remarkably p68 has also very recently been shown to interact in a complex with NonO and SFPQ/PSF\[[@B23]\], again confirming the validity of the technique described here.

Discussion
==========

The technique described here has proven useful in increasing the stringency of Oncomine™ meta-analysis, and will prove to be widely applicable. Generally individual gene levels cannot be compared from one study to another, but the strength of our analysis is an inter-study comparison (meta-analysis) after an intra-study Oncomine™ analysis (coexpression gene search).

While we still retain the strongest 400 coexpressed genes from each multi-array, it becomes de-sorted when analyzing for frequency over different studies. An example is *EDEM1*(involved in protein folding in the ER), which is consistently one of the strongest correlated genes with p72, while having only a 32% frequency overlap. The same is true for p68 and Sp3 transcription factor with a frequency overlap of 37%, and very highly coexpressed in these individual studies. Conversely, the technique described here is useful for comparison of coexpressed genes which may not always have a high coexpression coefficient, giving another advantage over analysis of single studies.

An interesting exception is *RAB6A*with p68 which has both the highest frequency overlap with p68 (68%) and is almost always within the first 100 genes coexpressed with p68 in individual multi-array studies. A further exception is RNA helicase A (*DHX9*) which again has a high frequency of overlap with p68 (47%) and usually is within the first 50 coexpressed genes with p68. We have also shown here for the first time an interaction by immunoprecipitation of p68 (and also p72), with Dhx9.

Furthermore, the technique described here is most useful in clustering specific genes involved in pathways when meta-analysis hits from known interacting proteins can be overlapped. We observed with our example of p68 and p72 that the overlapping hits mainly clustered into the classes of ontology in which p68/p72 had already been reported, namely splicing and transcription, further acting as validation for this type of analysis.

While some new proposed pathways for p68/p72 cannot be through direct action (e.g. cytoskeletal remodelling or ER-protein folding) it remains possible that p68/p72 are involved in these pathways indirectly via splicing/transcription/controlling nuclear shuttling. We were encouraged by the fact that p68 and/or p72 coexpressed with previously published interacting proteins such as one-another, ILF3, hnRNPH1, hnRNPU, hnRNPA2/B1, SFRS5, Ddx3X, PIAS1, SUMO2, pinin, NonO and SFPQ and were further encouraged by observation of coexpression with members of pathways in which they were previously shown to act, such as estrogen receptor pathway (*XBP1*, *MTA1*, *ERBP*, *DDX5*, *DDX17*), ubiquitin pathway (*USPX9*, *UBE2J1*, *UBE3A*, *BIRC6*, *UCHL1*, *EDD*), translation (*EIF3S6*, *EIF1A*, *EIF3S10*, *PABPC1*, *EIF5*), and transcriptional repression (*HDAC2*, *HDAC7A*, *PNN*, *ELK3*, *CTBP1*, *MTA1*).

There also seems to be a more general role for p68 and p72 in nuclear receptor transcription pathways than first assumed (ERα pathway as above), for example *JMJD1C*, *THRAP1*, *THRAP2*, *RARA*, *RORA*, all coexpress with p68 and/or p72.

While it is clear that we have obtained a highly stringent list of potential pathway partners of p68 and p72, with regard to separable functions (i.e. non-overlapping genes of p68 and p72) we cannot say with confidence as genes generally clustered into the same pathways as for the overlapping list. This may be due to a high false-negative rate of this technique as we have used several levels of stringency, and will most likely exclude many true pathway partners of p68 and p72. However, this cost is offset by high quality results using our rigorous analysis.

Conclusion
==========

It is apparent that we have increased the scope of the Oncomine™ database, by utilising frequency of coexpression (meta-analysis) over different multi-array studies to predict pathway partners of searched proteins. With regard to the p68 and p72 RNA helicases we have identified a non-exhaustive list of gene products that are likely to be present in various pathways in which p68 and/or p72 act, both corroborating previous studies and making novel predictions. For one of these, RNA helicase A(Dhx9), we have shown there is a direct interaction with p68 and p72. Future experimental studies using this list as a reference point will reveal the validity of this technique.

Methods
=======

Oncomine analysis
-----------------

The following procedure was undertaken for meta-analysis (figure [1B](#F1){ref-type="fig"}):

\(1\) Oncomine™ expression correlations were searched for p68 (*DDX5*) or p72(*DDX17*). (2) 19 different mult-arrays were chosen and the first 400 correlated genes within each multi-array were compared using Microsoft Excel, (separately for p68 and p72). Importantly, repetitive genes were then removed within each study, leaving only 1 representative per multi-array study. When a coregulated gene appeared in more than 3 multi-array experiments it was accepted as significant (3 = 16% frequency of the 19). These genes were taken as more significant than analysis of a single Oncomine™ output. Furthermore, given that the user cannot choose which multi-array will be given by Oncomine™ there was no attempt to specifiy different tissue types or cancer types. This had the advantage of giving a more generalised result of which pathways the proteins may be involved in, which was preferred for an initial study such as that performed here. (3) These sorted lists of coregulated genes given for p68 and p72 were compared for overlapping genes which added another level of stringency, and greatly increased the significance of the results. The genes listed were then investigated for ontology, and full gene/gene-product names, using a combination of Pubmed searches\[[@B24]\], Fatigo\[[@B25]\], and Genecards\[[@B26]\].

Cell culture, transfection, immunoprecipitation and western blot
----------------------------------------------------------------

HEK293 cells were transfected with either pSG5-myc, pSG5-myc-p68, pSG5-myc-p72 (plasmids were a gift from Frances Fuller-Pace, Dundee, UK), using FuGENE 6 (Roche). 48 h post-transfection cells were harvested on ice in buffer B (150 mM KCl, 0.1% NP-40, 20 mM Tris-HCl pH8.0, 5 mM MgCl~2~, 10% glycerol, 5 mM NaF, 1× Roche complete protease inhibitor cocktail). 600 μg of total cell extract was incubated with 5 μg 9E10 anti-myc monoclonal antibody, and protein G sepharose (GE Healthcare), rotating at 4°C for 2 h. Pellet was washed 3× in buffer B, boiled in protein loading buffer that was then run on an SDS-PAGE gel, transferred to pvdf and immunoblotted overnight at 4°C for Dhx9 (Bethyl Laboratories) or myc.

For endogenous co-immunoprecipitation liver was extracted from a 3 mth old male mouse and homogenised in buffer B (Brinkmann polytron). Lysis was allowed to happen, rotating at 4°C for 30 min. Sample was then centrifuged to remove debris and further incubated with RNaseA, rotating at 4°C for 30 additional minutes, while preclearing lysate with protein G sepharose. 2 mg of this lysate was used with 3 μg of either p68 or p72 antibodies (Bethyl Laboratories) per immunoprecipitation, which were performed as above.
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###### Additional file 1

p68(*DDX5*) and p72(*DDX17*) coexpressed genes. Table of all coexpressed genes of p68 and p72 (individual analyses) with frequency cutoff of 3 multi-array studies.
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###### Additional file 2

*DHX9*coexpressed genes and overlaps with p68(*DDX5*) and p72(*DDX17*). Table of *DHX9*Oncomine meta-analysis for coexpressed genes. Frequency cutoff of 3 multi-array studies. Overlap with p68 and p72 individual coexpression gene lists is shown, as is the overlap with the p68:p72 common gene list.
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